VM 26, a semisynthetic podophyllin derivative (4-demethyl-epipodo-phyllotoxin-beta-d-thenylidine glucoside) has been tested in 67 patients with urinary bladder tumors. In 25 patients with stage T 1 significant prolongation of the disease-free interval was reached. In 25 cases with state T 3-4, the effect of VM 26 was not favorable.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
urinary bladder
8
bladder tumors
8
4-demethyl-epipodophyllotoxin-beta-d-thenylidine glucoside
4
glucoside treatment
4
treatment urinary
4
tumors semisynthetic
4
semisynthetic podophyllin
4
podophyllin derivative
4
derivative 4-demethyl-epipodo-phyllotoxin-beta-d-thenylidine
4
4-demethyl-epipodo-phyllotoxin-beta-d-thenylidine glucoside
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!